These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36315052)

  • 1. Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3
    Benito-Villalvilla C; de la Rocha-Muñoz A; López-Abente J; Eggel A; Bottoli I; Severin T; Woisetschläger M; Palomares O
    Allergy; 2023 Apr; 78(4):1060-1072. PubMed ID: 36315052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9.
    Tversky JR; Le TV; Bieneman AP; Chichester KL; Hamilton RG; Schroeder JT
    Clin Exp Allergy; 2008 May; 38(5):781-8. PubMed ID: 18318750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.
    Schroeder JT; Chichester KL; Bieneman AP
    J Allergy Clin Immunol; 2008 Feb; 121(2):486-91. PubMed ID: 18036648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab.
    Gasser P; Tarchevskaya SS; Guntern P; Brigger D; Ruppli R; Zbären N; Kleinboelting S; Heusser C; Jardetzky TS; Eggel A
    Nat Commun; 2020 Jan; 11(1):165. PubMed ID: 31913280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms.
    Kuo BS; Li CH; Chen JB; Shiung YY; Chu CY; Lee CH; Liu YJ; Kuo JH; Hsu C; Su HW; Li YF; Lai A; Ho YF; Cheng YN; Huang HX; Lung MC; Wu MS; Yang FH; Lin CH; Tseng W; Yang J; Lin CY; Tsai PH; Chang HK; Wang YJ; Chen T; Lynn S; Liao MJ; Wang CY
    J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35912861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells.
    Gill MA; Bajwa G; George TA; Dong CC; Dougherty II; Jiang N; Gan VN; Gruchalla RS
    J Immunol; 2010 Jun; 184(11):5999-6006. PubMed ID: 20410486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
    Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
    Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
    J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
    Gomez G
    Front Immunol; 2019; 10():175. PubMed ID: 30792720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis.
    Novak N; Allam JP; Hagemann T; Jenneck C; Laffer S; Valenta R; Kochan J; Bieber T
    J Allergy Clin Immunol; 2004 Aug; 114(2):364-70. PubMed ID: 15316517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligelizumab treatment for severe asthma: learnings from the clinical development programme.
    Trischler J; Bottoli I; Janocha R; Heusser C; Jaumont X; Lowe P; Gautier A; Pethe A; Woessner R; Zerwes HG; Zielen S
    Clin Transl Immunology; 2021; 10(3):e1255. PubMed ID: 33747510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children.
    Durrani SR; Montville DJ; Pratt AS; Sahu S; DeVries MK; Rajamanickam V; Gangnon RE; Gill MA; Gern JE; Lemanske RF; Jackson DJ
    J Allergy Clin Immunol; 2012 Aug; 130(2):489-95. PubMed ID: 22766097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab.
    Gill MA; Liu AH; Calatroni A; Krouse RZ; Shao B; Schiltz A; Gern JE; Togias A; Busse WW
    J Allergy Clin Immunol; 2018 May; 141(5):1735-1743.e9. PubMed ID: 28870461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale for development of ligelizumab in food allergy.
    Wood RA; Chinthrajah RS; Eggel A; Bottoli I; Gautier A; Woisetschlaeger M; Tassinari P; Altman P
    World Allergy Organ J; 2022 Sep; 15(9):100690. PubMed ID: 36185545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.
    Janovec V; Aouar B; Font-Haro A; Hofman T; Trejbalova K; Weber J; Chaperot L; Plumas J; Olive D; Dubreuil P; Nunès JA; Stranska R; Hirsch I
    Front Immunol; 2018; 9():364. PubMed ID: 29535732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal allergy is associated with surface-bound IgE on cord blood basophils.
    Matson AP; Cloutier MM; Dhongade A; Puddington L; Rafti E
    Pediatr Allergy Immunol; 2013 Sep; 24(6):614-21. PubMed ID: 23980848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.
    Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG
    Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FcεRI.
    Maggi L; Rossettini B; Montaini G; Matucci A; Vultaggio A; Mazzoni A; Palterer B; Parronchi P; Maggi E; Liotta F; Annunziato F; Cosmi L
    Eur J Immunol; 2018 Dec; 48(12):2005-2014. PubMed ID: 30252930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the high-affinity IgE receptor on peripheral blood dendritic cells: differential binding of IgE in atopic asthma.
    Holloway JA; Holgate ST; Semper AE
    J Allergy Clin Immunol; 2001 Jun; 107(6):1009-18. PubMed ID: 11398078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
    Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
    Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.